GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI International Medical Inc (NAS:BIMI) » Definitions » Cash Conversion Cycle

BIMI International Medical (BIMI International Medical) Cash Conversion Cycle : 80.43 (As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is BIMI International Medical Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

BIMI International Medical's Days Sales Outstanding for the three months ended in Sep. 2023 was 189.81.
BIMI International Medical's Days Inventory for the three months ended in Sep. 2023 was 270.38.
BIMI International Medical's Days Payable for the three months ended in Sep. 2023 was 379.76.
Therefore, BIMI International Medical's Cash Conversion Cycle (CCC) for the three months ended in Sep. 2023 was 80.43.


BIMI International Medical Cash Conversion Cycle Historical Data

The historical data trend for BIMI International Medical's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI International Medical Cash Conversion Cycle Chart

BIMI International Medical Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 10.47 29.48 27.52

BIMI International Medical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.78 53.14 -42.39 15.40 80.43

Competitive Comparison of BIMI International Medical's Cash Conversion Cycle

For the Pharmaceutical Retailers subindustry, BIMI International Medical's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIMI International Medical's Cash Conversion Cycle Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BIMI International Medical's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where BIMI International Medical's Cash Conversion Cycle falls into.



BIMI International Medical Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

BIMI International Medical's Cash Conversion Cycle for the fiscal year that ended in Dec. 2022 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=140.12+182.74-295.34
=27.52

BIMI International Medical's Cash Conversion Cycle for the quarter that ended in Sep. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=189.81+270.38-379.76
=80.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIMI International Medical  (NAS:BIMI) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


BIMI International Medical Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of BIMI International Medical's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


BIMI International Medical (BIMI International Medical) Business Description

Traded in Other Exchanges
N/A
Address
Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010
BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.
Executives
Ang Sammi Ean Seok director 2658 VISTA MONTE CIRCLE, CHINO HILLS CA 91709
Fnu Oudom director 7700 IRVINE CENTRE DRIVE, SUITE 800, IRVINE CA 92618
Xiaoping Wang director ROOM 4-6,NO.88-4 HUAYAN FIRST VILLAGE, SHAPINGBA DISTRICT, CHONGQING F4 400037
Baiqun Zhong officer: CFO 1-7, NO.27, HUAYAN NEW VILLAGE, JIULONGPO DISTRICT, CHONGQING F4 400039
Zhang Tingting director, officer: Chief Financial Officer 3708, FULI CENTER, NO.6 GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001
Song Tiewei director 17 FLOOR, FULI CENTER NO.6,GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001
Yongquan Bi 10 percent owner ROOM 3708, WANDA PLACE, 6 GANGWAN ROAD, ZHONGSHAN DISTRICT, DALIAN CITY, LIAONING PROVINCE F4 116001
Wang Lihua director, 10 percent owner, officer: Chief Financial Officer NO 4 4 12 58 BAJING ROAD, HEPING DISTRICT SHENYANG CITY, LIAONING PROVINCW F4 110003
Li Gang director, 10 percent owner, officer: President and CEO 19B3 62 WEST HINHE ROAD, SHENHE DISTRICT SHENYANG CITY, LIAONING PROVINCE F4 110000
Jiuding Yan director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Lesley Jin director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Maclean John Coleman director 112 E 4TH AVE, SUITE 206, OLYMPIA WA 98501
Zhongmin Wang director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Jianxin Wang director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021
Mia Kuang Ching director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021

BIMI International Medical (BIMI International Medical) Headlines

From GuruFocus

BIMI Announces Entering into a $5 million Stock Purchase Agreement

By GuruFocusNews GuruFocusNews 06-30-2022

BIMI Announces Appointment of New Chairman and Independent Director

By GuruFocusNews GuruFocusNews 06-17-2022

BIMI Announces Entering into a $5 million Stock Purchase Agreement

By GuruFocusNews GuruFocusNews 07-10-2022

BIMI Announces 1-for -10 Reverse Stock Split

By Value_Insider Value_Insider 12-08-2022

BIMI Announces Appointment of Mr. Fnu Oudom to Board of Directors

By GuruFocusNews GuruFocusNews 06-01-2022

BIMI Announces Appointment of Mr. Fnu Oudom to Board of Directors

By GuruFocusNews GuruFocusNews 05-22-2022

BIMI Announces Appointment of New Chairman and Independent Director

By GuruFocusNews GuruFocusNews 05-28-2022

BIMI Announces Appointment of New Chairman and Independent Director

By GuruFocusNews GuruFocusNews 06-27-2022